The global minimally invasive neurosurgery devices market is valued at approximately USD 3,227.9 million in 2023, with projections indicating a robust growth trajectory. The market is expected to witness an average compound annual growth rate (CAGR) of 6.3% from 2023 to 2033, potentially exceeding USD 5,950.1 million by the end of the forecast period.
Key Market Insights
Demographic Drivers:
The increasing population of older adults and the rising prevalence of chronic illnesses such as cancer and neurological disorders are the primary factors fueling the growth of the minimally invasive neurosurgery devices market. As the demand for effective surgical solutions rises, healthcare providers are increasingly turning to minimally invasive techniques that offer faster recovery times and reduced complications.
Gastrointestinal Devices Segment:
The gastrointestinal category is anticipated to capture a significant market share due to the growing incidence of gastrointestinal disorders among young, adult, and elderly populations worldwide. This trend reflects the need for innovative surgical solutions that can address these health challenges effectively.
North America Leading the Market:
North America continues to dominate the minimally invasive neurosurgery devices market, driven by the high prevalence of neurological conditions affecting over 25 million people in the region. Neurological disorders are recognized as a leading cause of mortality, leading to increased demand for advanced surgical interventions.
Asia Pacific Growth Potential:
The Asia Pacific region is projected to experience substantial growth in the minimally invasive neurosurgery devices market, fueled by a growing patient population requiring surgical procedures and government initiatives aimed at enhancing the healthcare sector. This region’s increasing investment in healthcare infrastructure is expected to drive further market expansion.
Future Outlook
As the global minimally invasive neurosurgery devices market continues to evolve, advancements in technology and increasing awareness of the benefits of minimally invasive procedures are expected to play crucial roles in shaping the future of neurosurgery.
Competitive Landscape of the Minimally Invasive Neurosurgery Devices Market
Many market players have taken various measures. They create new devices and expand their businesses. They correspondingly make continuous investments to introduce improved devices. They also form strategic alliances with hospitals, research institutions, and other healthcare stakeholders. These strategies help them maintain their footing in the highly competitive industry.
Recent Developments in the Minimally Invasive Neurosurgery Devices Market
- In August 2023, Orthofix Medical revealed the complete commercial availability of their 7D Flash navigation system percutaneous module 2.0 in the United States. It adds additional planning elements and expands the usefulness of the 7D Flash neuronavigation system for minimally invasive spine surgery. The 7D system was provided by 7D Surgical, which was subsequently purchased by SeaSpine in 2021 following the merger of Orthofix and SeaSpine this year.
- In October 2022, for the very first time, Imperial College London scientists efficiently implanted a bioinspired, fresh, flexible, steerable device in the brains of living animals using a minimally invasive robot. It’s a highly accurate, minimally intrusive platform that advances current technologies. If shown safe and successful, it might increase its ability to effectively and securely detect and treat illnesses in humans.
Key Companies Profiled in the Minimally Invasive Neurosurgery Devices Market Report
- Karl Storz GmbH & Co. KG
- Olympus Corporation
- Conmed Corporation
- Richard Wolf GmbH
- Boston Scientific Inc.
- Integra LifeSciences Holdings Corporation
- Aesculap Division
- Smith & Nephew Plc
- Medtronic
- NICO Corp.
Key Segments Covered in the Minimally Invasive Neurosurgery Devices Industry Analysis
By Device Type:
- Surgical Devices
- Monitoring & Visualization Devices
- Endoscopy Devices
By Surgery Type:
- Urological
- Vascular
- Cardiac
- Gynaecological
- Gastrointestinal
- Cosmetic
- Bariatric
- Thoracic
- Breast
- Orthopedic
By Region:
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East & Africa
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube